A. Markkula, M. Hjertberg, C. Rose, C. Ingvar, and H. Jernström, “No association found between CYP2D6 genotype and early breast cancer events in tamoxifen-treated patients”, AO, vol. 53, no. 2, pp. 195–200, Feb. 2014.